Unknown

Dataset Information

0

Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy.

ABSTRACT:

SUBMITTER: Shi Y 

PROVIDER: S-EPMC8074628 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy.

Shi Yu Y   Hunter Sean S   Hunter Tony T  

Molecular cancer therapeutics 20190801 8

Similar Datasets

Unknown Cell Therapy as Target Therapy against Colon Cancer Stem Cells.
| S-EPMC10179203 | biostudies-literature
Unknown F77 antigen is a promising target for adoptive T cell therapy of prostate cancer.
| S-EPMC10591779 | biostudies-literature
Unknown Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapy
| S-EPMC12128359 | biostudies-literature
Unknown B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
| S-EPMC5045411 | biostudies-literature
Unknown Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy.
| S-EPMC5294253 | biostudies-literature
Unknown Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer.
| S-EPMC8901631 | biostudies-literature
Unknown Stem cell therapy: A promising treatment for COVID-19.
| S-EPMC8717529 | biostudies-literature
Unknown Stem cell therapy as a promising strategy in necrotizing enterocolitis.
| S-EPMC9450300 | biostudies-literature
Unknown Elongation factor 2 in cancer: a promising therapeutic target in protein translation.
| S-EPMC11660736 | biostudies-literature
Unknown Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.
| S-EPMC9218565 | biostudies-literature